Literaturnachweis - Detailanzeige
Autor/inn/en | DeMayo, Marilena M.; Pokorski, Izabella; Song, Yun J. C.; Thapa, Rinku; Patel, Shrujna; Ambarchi, Zahava; Soligo, Domenic; Sadeli, Indra; Thomas, Emma E.; Hickie, Ian B.; Guastella, Adam J. |
---|---|
Titel | The Feasibility of Magnetic Resonance Imaging in a Non-Selective Comprehensive Clinical Trial in Pediatric Autism Spectrum Disorder |
Quelle | In: Journal of Autism and Developmental Disorders, 52 (2022) 3, S.1211-1222 (12 Seiten)
PDF als Volltext |
Zusatzinformation | ORCID (Guastella, Adam J.) |
Sprache | englisch |
Dokumenttyp | gedruckt; online; Zeitschriftenaufsatz |
ISSN | 0162-3257 |
DOI | 10.1007/s10803-021-05028-2 |
Schlagwörter | Diagnostic Tests; Brain; Medicine; Autism; Pervasive Developmental Disorders; Children; Outcomes of Treatment; Clinical Diagnosis |
Abstract | There is an increasing interest in using magnetic resonance imaging (MRI) as a tool for precision medicine in autism spectrum disorder (ASD). This study investigated the feasibility of MRI scanning in a large comprehensive, inclusive and test heavy clinical trial for children (aged 3-12 years) with ASD, without functioning constraints for participation. Of the 71 participants enrolled who consented to the MRI, 24 participants (38%) successfully completed an MRI scan at baseline along with other assessments. This scanning followed a familiarization procedure at two preceding visits. At post-treatment, 21 participants successfully completed the MRI scan. This study highlights the challenge of completing MRI assessments in ASD populations when conducted as one of a number of tests in a clinical trial. (As Provided). |
Anmerkungen | Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/ |
Erfasst von | ERIC (Education Resources Information Center), Washington, DC |
Update | 2024/1/01 |